Science Applications International Corporation · NASDAQ:SAIC
Science Applications International — FY2021 Earnings Presentation
15 slides from Science Applications International's earnings presentation, Mar 25, 2021
Slide 1: Fiscal Year 2021 Fourth Quarter and Year End Earnings Call
Science Applications International Corporation (SAIC) Fiscal Year 2021 Fourth Quarter and Year End Earnings Call Supplemental Financial Presentation March 25, 2021
Slide 2: Forward Looking Statement
Forward Looking Statement Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “antici
Slide 3: Today's Presenters
Today’s Presenters Nazzic Keene Prabu Natarajan Chief Executive Officer Chief Financial Officer 3 © SAIC. All rights reserved. S A I C P R O P R I E T A R Y
Slide 4: FY2021 Q4 Highlights
FY2021 Q4 Highlights Solid Financial Results Share Repurchases Re-Initiated Q4 Total Revenue Growth of 11% (1% Internal Growth) * Q4 Adjusted EBITDA Margin of 9.3% Continued Rapid De-Levering; Net Leverage of 3.7x Q4 Book-to-Bill of 0.4x Full Fiscal Year Book-to-Bill of 1.7x Solid Performance in a C
Slide 5: SAIC Fourth Quarter FY2021 Results
(1) SAIC Fourth Quarter FY2021 Results ADJUSTED ADJUSTED REVENUE FREE CASH FLOW (2)(5) EBITDA MARGIN (2)(3) DILUTED EPS (2)(4) +60 bps -13% +11% $1,717M 9.3% +6% $62M 8.7% $1.67 $54M $1.58 $1,540M FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 Q4 Q4 Q4 Q4 Q4 Q4 Q4 Q4 (1) Results of Science
Slide 6: SAIC FY2021 Results
(1) SAIC FY2021 Results ADJUSTED ADJUSTED REVENUE FREE CASH FLOW (2)(5) EBITDA MARGIN (2)(3) DILUTED EPS (2)(4) +11% +50 bps +11% +20% $7,056M 8.9% $6.27 $524M $6,379M 8.4% $5.66 $437M FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 (1) Results of Science Applications International Corporati
Slide 7: Fiscal Year 2022 Guidance
Fiscal Year 2022 Guidance CURRENT • $150M to $200M of unfavorable impact Revenue $7.1B – $7.3B due to COVID-19 * • $10M to $15M unfavorable pre-tax impact Adjusted EBITDA % 8.6% to 8.8% due to COVID-19 • Effective tax rate of ~24% * Adjusted Diluted EPS $6.00 – $6.25 • Interest expense of ~$110M • D
Slide 8: Fiscal Year 2022 Guidance Walks
Fiscal Year 2022 Guidance Walks REVENUE FY21 Actual $7,056M New business (net) Up to $150M COVID-19 recovery (net) $50M to $100M FY22 Guidance $7,100M to $7,300M ADJUSTED EBITDA % FREE CASH FLOW * FY21 Actual 8.9% FY21 Actual $524M FY21 Non-recurring program Payroll tax deferral and payment ($155M)
Slide 9: Appendix
Appendix SAIC.
Slide 10: Working Days Per Quarter
Working Days Per Quarter Q1 Q2 Q3 Q4 Total FY22 64 63 63 60 250 FY21 64 63 63 60 250 FY20 64 63 63 60 250 FY19 64 63 63 60 250 10 © SAIC. All rights reserved. S A I C P R O P R I E T A R Y
Slide 11: Pay Periods Per Quarter
Pay Periods Per Quarter Q1 Q2 Q3 Q4 Total FY22 6 7 6 7 26 FY21 6 7 6 7 26 FY20 6 7 6.5* 7 26 FY19 6 7 6 7 26 *During the third quarter of fiscal year 2020 and as a result of a systems conversion due to the Engility acquisition, legacy Engility employees were paid a one week payroll cycle in order to
Slide 12: Non-GAAP Reconciliation — EBITDA and Adjusted EBITDA
Non-GAAP Reconciliation — EBITDA and Adjusted EBITDA (1) “EBITDA“ and “Adjusted EBITDA” are non-GAAP financial measures that are reconciled in this schedule to the most directly comparable GAAP financial measures. These non-GAAP financial measures help investors better understand profitability trend
Slide 13: Non-GAAP Reconciliation — Adjusted Diluted Earnings per Share
Non-GAAP Reconciliation — Adjusted Diluted Earnings per Share (1) “Adjusted diluted earnings per share” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibil
Slide 14: Non-GAAP Reconciliation — Free Cash Flow
Non-GAAP Reconciliation — Free Cash Flow (1) “Free cash flow” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibility into cash flows provided by operating
Slide 15: Non-GAAP Reconciliation — FY22 Free Cash Flow Guidance
Non-GAAP Reconciliation — FY22 Free Cash Flow Guidance (1) “Free cash flow” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibility into cash flows provided
Science Applications International — FY2021 Earnings Presentation on 6ix